Use of Amniotic Membrane in MMC-Augmented Trabeculectomy: A Retrospective Comparative Study.
amniotic membrane
antifibrotics
glaucoma
mitomycin C
scarring
trabeculectomy
Journal
Clinical ophthalmology (Auckland, N.Z.)
ISSN: 1177-5467
Titre abrégé: Clin Ophthalmol
Pays: New Zealand
ID NLM: 101321512
Informations de publication
Date de publication:
2021
2021
Historique:
received:
15
10
2021
accepted:
18
11
2021
entrez:
6
12
2021
pubmed:
7
12
2021
medline:
7
12
2021
Statut:
epublish
Résumé
Amniotic membrane transplantation (AMT) has shown promising results as an antifibrotic agent in trabeculectomy. We aimed to evaluate the additional effect of AMT in MMC-augmented trabeculectomy. This retrospective study analyzed the results of the first 12 postoperative months of glaucomatous eyes submitted to Moorfields Safer Surgery Trabeculectomy with MMC alone (non-AMT group) compared to MMC and AMT (AMT group). Both groups were compared in terms of intraocular pressure (IOP), number of antihypertensive medications and need for surgical reinterventions. Absolute and relative success rates 12 months after surgery were defined as IOP <18 mmHg, without and with the use of antihypertensive medications, respectively. The analysis included 51 eyes of 45 glaucoma patients (29 eyes in the non-AMT group and 22 in the AMT group). Mean IOP decreased from 24.72±5.11 mmHg and 26.86±10.62 mmHg preoperatively in non-AMT and AMT groups to 12.86±4.22 mmHg and 12.60±4.43 mmHg, respectively, at 12 months (p = 0.84). Postoperative number of medications decreased significantly in both groups. Absolute success was seen in 71% of non-AMT eyes and 55% of AMT eyes (p = 0.46), whereas relative success was obtained in 14% and 30%, respectively (p = 0.55). Reinterventions were needed in 28% of the eyes (11 bleb injection/needling and 4 Ahmed tube implantation) in the non-AMT group and in 27% of the AMT group (10 bleb injection/needling and 1 Ahmed tube implantation) (p = 0.89). Trabeculectomy combined with MMC and AMT did not show better results than trabeculectomy with MMC alone.
Identifiants
pubmed: 34866897
doi: 10.2147/OPTH.S342593
pii: 342593
pmc: PMC8636844
doi:
Types de publication
Journal Article
Langues
eng
Pagination
4527-4533Informations de copyright
© 2021 Roque et al.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest in this work.
Références
Arq Bras Oftalmol. 2006 May-Jun;69(3):309-12
pubmed: 16936950
J Ophthalmol. 2017;2017:1645269
pubmed: 28815088
Ophthalmic Surg Lasers. 1998 May;29(5):428-31
pubmed: 9599369
Surv Ophthalmol. 2004 Jan-Feb;49(1):51-77
pubmed: 14711440
Clin Ophthalmol. 2012;6:205-12
pubmed: 22347791
Int J Ophthalmol. 2013 Aug 18;6(4):448-51
pubmed: 23991376
Cutan Ocul Toxicol. 2010 Sep;29(3):164-70
pubmed: 20441414
Am J Ophthalmol. 2018 Jul;191:xxv-xxix
pubmed: 29655641
Am J Ophthalmol. 1968 Oct;66(4):673-9
pubmed: 4891876
Indian J Ophthalmol. 2017 Nov;65(11):1151-1155
pubmed: 29133641
Yan Ke Xue Bao. 2005 Jun;21(2):126-31
pubmed: 17165346
Yan Ke Xue Bao. 2000 Jun;16(2):73-6, 83
pubmed: 12579907
Dev Ophthalmol. 2017;59:15-35
pubmed: 28442684
PLoS One. 2014 Jan 20;9(1):e85782
pubmed: 24465704
Curr Opin Ophthalmol. 2004 Apr;15(2):141-6
pubmed: 15021227
J Glaucoma. 2015 Sep;24(7):556-9
pubmed: 24844538
J Glaucoma. 2015 Jan;24(1):1-8
pubmed: 23661044
J Glaucoma. 2008 Jun-Jul;17(4):303-7
pubmed: 18552616